26.71
0.72 (2.77%)
| Penutupan Terdahulu | 25.99 |
| Buka | 26.07 |
| Jumlah Dagangan | 115,141 |
| Purata Dagangan (3B) | 405,070 |
| Modal Pasaran | 858,237,184 |
| Harga / Pendapatan (P/E TTM) | 14.36 |
| Harga / Pendapatan (P/E Ke hadapan) | 3.95 |
| Harga / Jualan (P/S) | 1.73 |
| Harga / Buku (P/B) | 3.79 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 May 2025 |
| Margin Keuntungan | 10.96% |
| Margin Operasi (TTM) | 23.97% |
| EPS Cair (TTM) | 1.86 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 21.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -60.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 428.20% |
| Nisbah Semasa (MRQ) | 0.950 |
| Aliran Tunai Operasi (OCF TTM) | 204.98 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 362.08 M |
| Pulangan Atas Aset (ROA TTM) | 8.89% |
| Pulangan Atas Ekuiti (ROE TTM) | 32.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | Collegium Pharmaceutical, Inc. | Menurun | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 1.00 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.44% |
| % Dimiliki oleh Institusi | 118.15% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 50.00 (HC Wainwright & Co., 87.20%) | Beli |
| Median | 46.00 (72.22%) | |
| Rendah | 37.00 (Piper Sandler, 38.53%) | Pegang |
| Purata | 44.33 (65.97%) | |
| Jumlah | 2 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 18.98 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Piper Sandler | 09 May 2025 | 37.00 (38.53%) | Pegang | 0.000 |
| Needham | 09 Apr 2025 | 46.00 (72.22%) | Beli | 26.37 |
| HC Wainwright & Co. | 24 Mar 2025 | 50.00 (87.20%) | Beli | 30.56 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |